Charles River Laboratories International, Inc.
CRL
$162.85
-$5.84-3.46%
NYSE
| 03/28/2026 | 12/27/2025 | 09/27/2025 | 06/28/2025 | 03/29/2025 | |
|---|---|---|---|---|---|
| Net Income | 94.63% | -608.17% | 4.01% | 105.45% | 111.87% |
| Total Depreciation and Amortization | -46.18% | 780.94% | -90.86% | 97.05% | 21.01% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -67.58% | 94.52% | 1,182.14% | -120.97% | -81.13% |
| Change in Net Operating Assets | -1,666.44% | 231.62% | -146.07% | 767.68% | 103.04% |
| Cash from Operations | -72.15% | -31.01% | 4.51% | 19.17% | 7.74% |
| Capital Expenditure | 37.15% | -150.00% | -0.80% | 40.50% | 21.55% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -100.00% | -- |
| Other Investing Activities | -82.19% | -304.72% | 192.31% | 43.24% | -636.89% |
| Cash from Investing | -339.45% | -175.42% | 9.76% | 17.90% | 40.24% |
| Total Debt Issued | 482.40% | 45.75% | -80.35% | 31.39% | 297.28% |
| Total Debt Repaid | -71.15% | 18.12% | 65.63% | -394.20% | 15.49% |
| Issuance of Common Stock | 72.01% | 35,450.00% | 100.00% | -- | -- |
| Repurchase of Common Stock | -216,863.54% | -3.23% | 98.74% | 97.92% | -284,683.87% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -49.81% | 78.57% | 77.97% | -47.75% | -321.40% |
| Cash from Financing | 770.45% | 66.02% | 32.74% | -115.45% | -38.81% |
| Foreign Exchange rate Adjustments | -68.23% | 229.47% | -123.95% | 140.63% | 139.15% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -362.59% | -72.32% | 152.10% | -279.63% | 530.94% |